Skip to main content
Cancer Explained
Donate

NewsIn memory

Rush Limbaugh and Lung Cancer: Understanding the Diagnosis

Radio host Rush Limbaugh shared that he had advanced lung cancer. Here's a calm, plain-language look at what lung cancer is.

By Cancer Explained Editorial TeamPublished Updated

A plain-language summary based on public reporting and trusted sources, linked below.

A woman sits on a couch with a laptop, resting her head on her hand, looking tired
A woman sits on a couch with a laptop, resting her head on her hand, looking tired — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

It started with breathlessness

On February 3, 2020, Rush Limbaugh told his radio audience that he had advanced lung cancer. He described how it began. Reporting on the announcement says he first began experiencing shortness of breath on January 12, and that two medical institutions had confirmed the diagnosis by January 20. He said he would step away briefly for tests and treatment planning, and hoped to keep hosting.

He died on February 17, 2021, at the age of 70. His wife announced it on his show.

He did not release the histologic type of his cancer, and no reputable account describes his treatment in detail. This article stops there. What is worth pulling out is that opening symptom, because breathlessness with no obvious cause is one of the most commonly ignored signs in medicine.

What "advanced" means

Doctors use "advanced" loosely and "metastatic" precisely. NCI defines metastatic cancer as cancer that has spread from where it started to a distant part of the body.

Getting there takes several steps. NCI describes cancer cells invading nearby tissue, pushing through the walls of lymph vessels or blood vessels, traveling in the lymphatic system or bloodstream, halting in small vessels at a distant site, invading the tissue there, and then prompting new blood vessels to grow and feed the deposit.

For lung cancer, NCI lists the usual destinations: the adrenal gland, bone, brain, liver, and the other lung.

That list explains why the first sign of lung cancer is sometimes nothing to do with breathing. NCI notes that bone deposits cause pain and fractures, brain deposits cause headache, seizures, or dizziness, liver deposits cause jaundice or abdominal swelling, and deposits in lung tissue cause shortness of breath.

Why breath is the symptom to take seriously

Breathlessness creeps. It arrives slowly enough that people adjust around it, taking the elevator, parking closer, cutting the walk short, and calling it age or weight or being out of shape.

In lung cancer, several separate mechanisms can produce it. A tumor can block an airway. Fluid can collect between the lung and the chest wall, which NCI counts as stage M1a disease when that fluid contains cancer cells. Deposits scattered through lung tissue can reduce how much of the lung still works.

None of that is diagnosed by waiting. A chest x-ray or CT scan answers the question in an afternoon.

When to get checked

Book an appointment for any of these, and describe the timeline precisely:

  • New breathlessness on an activity you handled comfortably six months ago.
  • A cough that has lasted more than three weeks, or a long-standing cough that has changed.
  • Coughing up blood, even once, in any amount.
  • Chest, shoulder, or back pain that persists without an injury.
  • Hoarseness for more than three weeks with no cold to explain it.
  • Two or more chest infections in a short period.
  • Unintended weight loss, or a marked drop in appetite.
  • New headaches with nausea, a first seizure, bone pain that wakes you at night, or yellowing of the skin, all of which can signal spread.

Most people with these symptoms do not have cancer. The visit exists to rule it out quickly rather than to confirm anything.

Screening, for the people it fits

Symptoms are not screening. Screening tests people who feel fine.

The US Preventive Services Task Force recommends annual low-dose CT for adults aged 50 to 80 who have a 20 pack-year smoking history and who currently smoke or who quit within the past 15 years. Twenty pack-years is roughly a pack a day for 20 years. Screening stops after 15 smoke-free years, or when health problems would make curative surgery impossible.

The National Lung Screening Trial, which underpins this, found 20 percent fewer lung cancer deaths with low-dose CT than with chest x-ray, and calculated that 320 people needed screening to prevent one death. Harms exist too. In that trial, false-positive results came back in 27.3 percent of first-round CT screens, 27.9 percent in round two and 16.8 percent in round three, sometimes leading to procedures that were not needed.

What treatment involves once it has spread

NCI is straightforward that treatments exist for most types of metastatic cancer, and that the usual goal is control rather than cure. It also notes that some people live for years with metastatic cancer that is well controlled.

For lung cancer, the tissue itself decides the plan. NCI stresses that an experienced pathologist must separate small cell from non-small cell disease, because the treatments diverge entirely. Non-small cell tumors are then tested for changes in genes including EGFR, ALK, BRAF, ROS1, RET, NTRK, MET, KRAS, and HER2. A match can open the door to a targeted drug taken by mouth.

Immunotherapy and chemotherapy are the other systemic options. Radiation is used to relieve specific problems, such as a painful bone deposit or a blocked airway.

Palliative care belongs in this picture from the start. NCI defines it as care meant to improve quality of life for people with a serious illness, delivered alongside cancer treatment rather than after it, by a team that can include doctors, nurses, dietitians, pharmacists, chaplains, psychologists, and social workers.

The statistics, and what they leave out

The American Cancer Society projects 229,410 new lung and bronchus cancers and 124,990 deaths in the United States in 2026, and SEER, NCI's surveillance program, publishes those projections. Lung cancer is 10.8 percent of new cancer diagnoses and 20.0 percent of cancer deaths.

NCI's registry measurements, covering people diagnosed from 2016 to 2022, put five-year relative survival at 65.5 percent for localized disease, 38.2 percent for regional spread, and 10.5 percent when the disease has reached distant sites. Fully 51 percent of cases are already distant at diagnosis, which is the central reason the overall figures look as they do.

Those percentages come from large groups diagnosed in past years, some before current targeted and immune therapies were available. They describe populations, not people. No table can tell an individual what their own course will be.

Sources

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI